Serum sTWEAK and FGF-23 levels in hemodialysis and renal transplant patients
MetadataShow full item record
Background: Kidney transplantation is the treatment of choice for patients with end-stage renal disease. Objective: To evaluate the changes in serum soluble TNF-like weak inducer of apoptosis (sTWEAK) and fibroblast growth factor 23 (FGF-23) in hemodialysis (HD) patients and renal transplant recipients (RTR). Methods: Serum samples were obtained from 30 patients on chronic HD, 30 RTRs, and 30 normal controls. Biochemical factors, sTWEAK, FGF-23, and interlukin-6 (IL-6) were measured by standard methods. Results: Serum levels of sTWEAK in RTRs were significantly higher than those in the HD patients (p=0.025); RTR and HD patients had significantly lower sTWEAK levels than the controls (p=0.001 and p= 0.038, respectively). Serum levels of FGF-23 in HD patients were significantly (p=0.001) higher than those in the RTR; the level was higher in both studied groups compared to that in the controls (p=0.001 for both groups). The mean serum level of IL-6 in HD was significantly higher than that in RTR patients (p=0.013). IL-6 levels in both groups were significantly higher than those in controls (p=0.001 and p= 0.012, respectively). In HD group a negative correlation was found between FGF-23 and sTWEAK (r= -0.375, p=0.041); there were also a significant correlation between FGF-23 and IL-6 (r= 0.480, p= 0.007) and between IL-6 and sTWEAK (r= -0.409, p=0.025). Conclusion: We found that serum sTWEAK is decreased and FGF-23 is increased in HD and RTR groups comparing with the control group. However, further studies are needed to shed light over their direct role on atherosclerosis and cardiovascular outcomes.
Showing items related by title, author, creator and subject.
Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women with Metabolic Syndrome Jabbari, M; Kheirouri, S; Alizadeh, M (2018)Objective We aimed to investigate the association between serum levels of ghrelin and brain-derived neurotrophic factor (BDNF) with MetS and its components in premenopausal women. Methods 43 patients with MetS and 43 healthy ...
Relationship of serum resistin level with insulin resistance indices in non-diabetic and diabetic obese subjects Mohammadzadeh, G; Zarghami, N; Larijani, B (2007)Background: Resistin, an adipocyte secreted factor, has been suggested to link obesity with type 2 diabetes and insulin resistance in rodent models but its relevance to human diabetes remains uncertain. The aim of this ...
Effects of aloe vera supplements on blood glucose level and lipid profile markers in type 2 diabetic patients - A randomized clinical trial Zarrintan, A; Mobasseri, M; Zarrintan, A; Ostadrahimi, A (2015)Background: One of the most studied methods to adjust the blood glucose level and dyslipidemia in diabetic patients is administrating of herbal supplements. This double blinded randomized clinical trial (RCT) study we are ...